Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (), is a COVID-19 vaccine developed by .
Clinical trials In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.
In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.
Authorizations On 9 June 2021, the vaccine has been approved by the Chinese authorities.
References
External links